Medicine and Dentistry
Patient
100%
Infection
58%
Hematologic Malignancy
53%
Therapeutic Procedure
40%
Inpatient
38%
Acute Myeloid Leukemia
37%
Systemic Mycosis
26%
COVID-19
25%
Diagnosis
23%
Mycosis
22%
Mortality
20%
Combination Therapy
19%
Antifungal Agent
19%
Antifungal Therapy
18%
Invasive Aspergillosis
17%
Diseases
15%
Mortality Rate
14%
Chemotherapy
13%
Neoplasm
13%
Prophylaxis
12%
Posaconazole
12%
Myelodysplastic Syndrome
11%
Cohort Effect
11%
Amphotericin B
10%
Acute Leukemia
10%
Bloodstream Infection
9%
Adult
9%
Neutropenia
9%
Mucormycosis
9%
Hematology
9%
Infectious Complication
8%
Voriconazole
8%
Hematopoietic Stem Cell Transplantation
8%
Stem Cell Transplant
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Azacitidine
7%
Allogeneic Hematopoietic Stem Cell Transplantation
7%
Age
7%
Pathogen
7%
Acute Lymphoblastic Leukemia
7%
Aspergillus
7%
Acute Myelogenous Leukemia
7%
Granulocyte Transfusion
7%
Transplantation
6%
Polymacon
6%
Retrospective Study
6%
Overall Survival
6%
Incidence
6%
Multiple Myeloma
5%
Plasmacytoid Dendritic Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
29%
Infection
27%
Systemic Mycosis
19%
Acute Myeloid Leukemia
17%
Mycosis
14%
Infection
13%
Hematologic Malignancy
13%
Mortality
12%
Posaconazole
11%
Acute Myeloid Leukemia
11%
Chemotherapy
11%
Leukemia
9%
Diseases
9%
Voriconazole
9%
Myelodysplastic Syndrome
8%
Amphotericin B
8%
Invasive Aspergillosis
8%
Bloodstream Infection
7%
Antifungal
7%
Antifungal Agent
7%
Invasive Aspergillosis
6%
Drug
6%
Mortality Rate
6%
Azacitidine
5%
Infectious Complication
5%
Mould
5%
Mycosis
5%
Immunology and Microbiology
Myeloid
8%
Mortality
7%
Mould
6%
